Proinnovera - Part of Symbio

At Symbio we transform over 25 years of dermatological experience into clinical trial excellence in the field of inflammatory diseases as a full-services CRO. We match our talent and experience with the latest innovative technologies to leverage clinical trial execution. Hands on, efficient, and with one goal; to deliver measurable performance in everything we do and for everyone we work with. Symbio Group is worldwide leader in conducting dermatology trials, but is also experienced in the following areas: - Dermatology & Aesthetics - Inflammatory Diseases - Oncology - Allergology We are a mid-sized CRO with offices in Germany and USA, offering full-service coverage and expertise in the largest clinical dermatology markets in the world.

Münster, North Rhine-Westphalia
Founded in 1997
11-50 employees

At Symbio we transform over 25 years of dermatological experience into clinical trial excellence in the field of inflammatory diseases as a full-services CRO. We match our talent and experience with the latest innovative technologies to leverage clinical trial execution. Hands on, efficient, and with one goal; to deliver measurable performance in everything we do and for everyone we work with. Symbio Group is worldwide leader in conducting dermatology trials, but is also experienced in the following areas: - Dermatology & Aesthetics - Inflammatory Diseases - Oncology - Allergology We are a mid-sized CRO with offices in Germany and USA, offering full-service coverage and expertise in the largest clinical dermatology markets in the world.

Company Information

Industry
Company Type
Privately Held
Founded
1997
Employee Range
11-50
Revenue Range
Not available

Location

Address
Wienburgstrasse 207 NRW Muenster
City
Münster
Region
North Rhine-Westphalia
Postal Code
48159
Country
Germany

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions